Total Payments
$44,501
2024 Payments
$39,422
Companies
33
Transactions
373
Medicare Patients
1,383
Medicare Billing
$165,227
Payment Breakdown by Category
Other$20,350 (45.7%)
Travel$9,037 (20.3%)
Consulting$8,250 (18.5%)
Food & Beverage$6,836 (15.4%)
Education$29.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,350 | 8 | 43.5% |
| Travel and Lodging | $9,037 | 24 | 20.3% |
| Consulting Fee | $8,250 | 3 | 18.5% |
| Food and Beverage | $6,836 | 331 | 15.4% |
| Honoraria | $1,000 | 1 | 2.2% |
| Education | $29.00 | 2 | 0.1% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$44,501
369 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $25,978 | 48 | $0 (2024) |
| Laborie Medical Technologies Corp. | $8,907 | 15 | $0 (2024) |
| Medtronic, Inc. | $2,949 | 29 | $0 (2024) |
| GastroGPO, LLC | $1,754 | 7 | $0 (2024) |
| ABBVIE INC. | $1,621 | 142 | $0 (2024) |
| Apollo Endosurgery US Inc | $677.36 | 5 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $327.07 | 26 | $0 (2024) |
| Vital Connect, Inc | $301.64 | 1 | $0 (2022) |
| Ardelyx, Inc. | $238.16 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $225.45 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,422 | 222 | Phathom Pharmaceuticals, Inc. ($25,978) |
| 2023 | $2,781 | 75 | GastroGPO, LLC ($1,754) |
| 2022 | $997.00 | 41 | Vital Connect, Inc ($301.64) |
| 2021 | $404.26 | 24 | AbbVie Inc. ($330.84) |
| 2020 | $21.80 | 1 | Covidien LP ($21.80) |
| 2019 | $168.32 | 3 | Covidien LP ($155.94) |
| 2018 | $29.00 | 2 | Alexion Pharmaceuticals, Inc. ($29.00) |
| 2017 | $677.36 | 5 | Apollo Endosurgery US Inc ($677.36) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), PLENVU | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $2.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: GI | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/22/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/21/2024 | Laborie Medical Technologies Corp. | alpHaONE (Device) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 455 | 823 | $218,591 | $56,400 |
| 2022 | 10 | 311 | 387 | $126,401 | $36,552 |
| 2021 | 11 | 319 | 408 | $122,514 | $40,146 |
| 2020 | 8 | 298 | 356 | $95,943 | $32,130 |
Total Patients
1,383
Total Services
1,974
Medicare Billing
$165,227
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 109 | $23,653 | $9,156 | 38.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 41 | 41 | $43,747 | $8,579 | 19.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 228 | $34,656 | $8,288 | 23.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 137 | $13,700 | $6,624 | 48.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 78 | $11,494 | $4,720 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 64 | $9,472 | $3,747 | 39.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 39 | 43 | $29,240 | $3,587 | 12.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 14 | 14 | $10,892 | $2,441 | 22.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $6,987 | $2,314 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $9,296 | $2,096 | 22.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $16,093 | $1,726 | 10.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,713 | $1,283 | 34.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,628 | $931.42 | 35.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 20 | 20 | $3,020 | $907.85 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 136 | $29,512 | $12,634 | 42.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 87 | $12,861 | $4,873 | 37.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 27 | 28 | $29,876 | $4,838 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $11,620 | $4,172 | 35.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 34 | 34 | $22,086 | $3,140 | 14.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $7,970 | $2,850 | 35.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $3,892 | $1,508 | 38.7% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 11 | 11 | $4,180 | $1,012 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 12 | $1,776 | $833.37 | 46.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,628 | $692.67 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 134 | $28,142 | $12,904 | 45.9% |
About Dr. Scott Pollack, M.D
Dr. Scott Pollack, M.D is a Gastroenterology healthcare provider based in Marrero, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366633166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Pollack, M.D has received a total of $44,501 in payments from pharmaceutical and medical device companies, with $39,422 received in 2024. These payments were reported across 373 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,350).
As a Medicare-enrolled provider, Pollack has provided services to 1,383 Medicare beneficiaries, totaling 1,974 services with total Medicare billing of $165,227. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Marrero, LA
- Active Since 08/06/2007
- Last Updated 11/13/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1366633166
Products in Payments
- VOQUEZNA (Drug) $25,978
- alpHaONE (Device) $8,888
- GI GENIUS (Device) $1,713
- RINVOQ (Biological) $668.27
- Orbera (Device) $396.40
- HUMIRA (Biological) $357.45
- SKYRIZI (Biological) $341.15
- ENTYVIO (Biological) $315.48
- ORBERA (Device) $280.96
- ENDOFLIP (Device) $243.84
- IBSRELA (Drug) $238.16
- ZEPOSIA (Drug) $191.93
- XIFAXAN (Drug) $166.45
- DUPIXENT (Biological) $158.13
- XELJANZ (Drug) $111.65
- CREON (Drug) $105.46
- VIBERZI (Drug) $79.47
- Linzess (Drug) $76.83
- STELARA (Biological) $61.81
- DIFICID (Drug) $59.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Marrero
Dr. Gary Reiss, Md, MD
Gastroenterology — Payments: $345,059
Gastroenterology $345,059
Dr. Shantiprakash Kedia, M.d, M.D
Gastroenterology — Payments: $11,746
Gastroenterology $11,746
Dr. Sanjeeva Reddy, M.d, M.D
Gastroenterology — Payments: $9,527
Gastroenterology $9,527
Brett Hymel, Md, MD
Gastroenterology — Payments: $6,171
Gastroenterology $6,171
James Campbell, Md, MD
Gastroenterology — Payments: $5,534
Gastroenterology $5,534
Dr. Charles Schibler, M.d, M.D
Gastroenterology — Payments: $3,046
Gastroenterology $3,046